Month: July 2021

In this article TSLA SpaceX founder and Tesla CEO Elon Musk visits the construction site of Tesla’s gigafactory in Gruenheide, near Berlin, Germany, May 17, 2021. Michele Tantussi | Reuters Tesla reports second-quarter results after the bell on Monday. Here’s what analysts are expecting, according to estimates compiled by Refinitiv: Earnings: 98 cents per share, adjusted, expected
0 Comments
In this article CROX Dina Rudick | Boston Globe | Getty Images Crocs reported second-quarter earnings that beat on the top and bottom line Thursday, raising its full-year revenue guidance amid strong global demand. The shoemaker’s stock jumped nearly 3% in premarket trading. Here’s how the company did compared with what analysts surveyed by Refinitiv
0 Comments
Anthony Scaramucci, former director of communications for the White House and founder of SkyBridge Capital LLC, speaks during the Skybridge Alternatives (SALT) conference in Las Vegas, Nevada, on May 8, 2019. Joe Buglewicz | Bloomberg | Getty Images Anthony Scaramucci, founder and co-managing partner of SkyBridge, told CNBC on Friday he’s mandated Covid shots at
0 Comments
In this article BIIB Aduhelm by Biogen Source: Biogen Biogen‘s Alzheimer’s drug, Adhulem, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. Biogen upped its revenue guidance for the year, saying it now
0 Comments
Thomasin McKenzie and Alex Wolff star in M. Night Shyamalan’s “Old.” Universal M. Night Shyamalan’s latest film “Old” has no shortage of intrigue and suspense, but fails to live up to the director’s previous work, critics say. His latest thriller follows a family of four, Guy (Gael Garcia Bernal), Prisca (Vicky Krieps) and their children,
0 Comments
In this article CYDY Young chemist working with chemical substances during scientific experiment in laboratory. skynesher | E+ | Getty Images Company: CytoDyn Inc. (CYDY) Business: CytoDyn is a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Its
0 Comments
In this article AXP INTC SAM HON TWTR S3 Studio | Getty Images Check out the companies making headlines in midday trading. Snap — Shares of Snap soared roughly 24% after better-than-expected second-quarter earnings results. The social media company reported strong growth of users, engagement and ads. Twitter — Twitter shares gained 3.4% after reporting its fastest revenue
0 Comments
California will strengthen the security of the debit cards it uses to issue unemployment insurance and other benefits following a wave of fraud, according to an announcement from the state’s Employment Development Department. The state agency plans to work with Bank of America to start rolling out chip-enabled debit cards to new claimants, as well
0 Comments
In this article SAM Boston Beer CEO David Burwick said Friday the company was surprised by the disappointing second-quarter sales of its Truly hard seltzer, telling CNBC in an interview that management does not “look very smart” after its prior forecast. “The trade-off from grocery and liquor store purchase and consuming at home to bars during
0 Comments